Zimmer Biomet - Rasio total nilai perusahaan marang pendapatan ZBH

Zimmer Biomet Holdings (ZBH) dominates the joint implant segment, leveraging the consistent demand of an aging population and a stable cash flow. The EV/Sales trend illustrates current price corridors, where the 3070.79 level captures the current state. Cost optimization via contract manufacturing accelerates the launch of new products, while expansion into robotic surgery and ambulatory centers extends its market influence.
Rincian metrik keuangan lan pasar Zimmer Biomet Holdings, Inc. (ZBH)

EV/Sales (co) measures the total enterprise value of the business, including debt, relative to annual revenue, thereby excluding the impact of credit load on the valuation. For Zimmer Biomet Holdings (ZBH), this filter is critical, as revenue scalability is driven by installed equipment and consistent demand for proprietary implants. Analyzing the enterprise value-to-revenue ratio on GURU.Markets allows investors to promptly identify asset overvaluation or determine a safe entry point.